Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Plos One|September 1, 2020
Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndromeMasahiro Sogabe, Toshiya Okahisa, Takeshi Kurihara, et al.
Internal Medicine (Tokyo, Japan)|January 18, 2021
An Adult Case of Congenital Extrahepatic Portosystemic Shunt Successfully Treated with Balloon-occluded Retrograde Transvenous ObliterationHironori Tanaka, Yoshihito Saijo, Tetsu Tomonari, et al.
Journal of Gastroenterology and Hepatology|January 11, 2024
Association of metabolic dysfunction-associated fatty liver disease with gallstone development: A longitudinal studyMasahiro Sogabe, Toshiya Okahisa, Miwako Kagawa, et al.
Plos One|June 3, 2017
The differing influence of several factors on the development of fatty liver with elevation of liver enzymes between genders with metabolic syndrome: A cross-sectional studyMasahiro Sogabe, Toshiya Okahisa, Masahiko Nakasono, et al.
BMC Gastroenterology|April 23, 2020
Effects of audio and visual distraction on patients' vital signs and tolerance during esophagogastroduodenoscopy: a randomized controlled trialMasahiro Sogabe, Toshiya Okahisa, Akira Fukuya, et al.
European Journal of Clinical Investigation|April 18, 2024
Impact of alcohol consumption on metabolic dysfunction-associated fatty liver disease development and remission: A longitudinal cohort studyMasahiro Sogabe, Toshiya Okahisa, Miwako Kagawa, et al.
Cancer Science|April 4, 2026
Orthotopic Esophageal Cancer Xenograft Model in Immunosuppressed Microminipigs for Near-Infrared Fluorescence EndoscopyTakanori Miyake, Yutaka Kawano, Takanori Kashihara, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 25, 2020
Comparison of therapeutic outcomes of sorafenib and lenvatinib as primary treatments for hepatocellular carcinoma with a focus on molecular-targeted agent sequential therapy: A propensity score-matched analysisTetsu Tomonari, Yasushi Sato, Joji Tani, et al.
Diabetes & Metabolic Syndrome|May 16, 2024
Association of variabilities in body mass index and waist circumference with newly achieved remission of metabolic dysfunction-associated fatty liver diseaseMasahiro Sogabe, Toshiya Okahis, Miwako Kagawa, et al.
Alimentary Pharmacology & Therapeutics|September 23, 2024
The association between alcohol consumption and cardiometabolic factors and liver fibrosis in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated liver diseaseMasahiro Sogabe, Toshiya Okahisa, Miwako Kagawa, et al.
Pageof 8